341 related articles for article (PubMed ID: 22711606)
1. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.
Barajas RF; Phillips JJ; Parvataneni R; Molinaro A; Essock-Burns E; Bourne G; Parsa AT; Aghi MK; McDermott MW; Berger MS; Cha S; Chang SM; Nelson SJ
Neuro Oncol; 2012 Jul; 14(7):942-54. PubMed ID: 22711606
[TBL] [Abstract][Full Text] [Related]
2. Super-resolution track density imaging of glioblastoma: histopathologic correlation.
Barajas RF; Hess CP; Phillips JJ; Von Morze CJ; Yu JP; Chang SM; Nelson SJ; McDermott MW; Berger MS; Cha S
AJNR Am J Neuroradiol; 2013 Jul; 34(7):1319-25. PubMed ID: 23413250
[TBL] [Abstract][Full Text] [Related]
3. Glioblastoma multiforme regional genetic and cellular expression patterns: influence on anatomic and physiologic MR imaging.
Barajas RF; Hodgson JG; Chang JS; Vandenberg SR; Yeh RF; Parsa AT; McDermott MW; Berger MS; Dillon WP; Cha S
Radiology; 2010 Feb; 254(2):564-76. PubMed ID: 20093527
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Cha S; Lupo JM; Chen MH; Lamborn KR; McDermott MW; Berger MS; Nelson SJ; Dillon WP
AJNR Am J Neuroradiol; 2007; 28(6):1078-84. PubMed ID: 17569962
[TBL] [Abstract][Full Text] [Related]
5. Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma.
Pirzkall A; McGue C; Saraswathy S; Cha S; Liu R; Vandenberg S; Lamborn KR; Berger MS; Chang SM; Nelson SJ
Neuro Oncol; 2009 Dec; 11(6):842-52. PubMed ID: 19229057
[TBL] [Abstract][Full Text] [Related]
6. Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM.
Essock-Burns E; Phillips JJ; Molinaro AM; Lupo JM; Cha S; Chang SM; Nelson SJ
J Magn Reson Imaging; 2013 Aug; 38(2):388-400. PubMed ID: 23281184
[TBL] [Abstract][Full Text] [Related]
7. Tumor Infiltration in Enhancing and Non-Enhancing Parts of Glioblastoma: A Correlation with Histopathology.
Eidel O; Burth S; Neumann JO; Kieslich PJ; Sahm F; Jungk C; Kickingereder P; Bickelhaupt S; Mundiyanapurath S; Bäumer P; Wick W; Schlemmer HP; Kiening K; Unterberg A; Bendszus M; Radbruch A
PLoS One; 2017; 12(1):e0169292. PubMed ID: 28103256
[TBL] [Abstract][Full Text] [Related]
8. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
9. Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.
Heo YJ; Kim HS; Park JE; Choi CG; Kim SJ
PLoS One; 2015; 10(8):e0136380. PubMed ID: 26296086
[TBL] [Abstract][Full Text] [Related]
10. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
[TBL] [Abstract][Full Text] [Related]
11. Spatial discrimination of glioblastoma and treatment effect with histologically-validated perfusion and diffusion magnetic resonance imaging metrics.
Prah MA; Al-Gizawiy MM; Mueller WM; Cochran EJ; Hoffmann RG; Connelly JM; Schmainda KM
J Neurooncol; 2018 Jan; 136(1):13-21. PubMed ID: 28900832
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance image-guided proteomics of human glioblastoma multiforme.
Hobbs SK; Shi G; Homer R; Harsh G; Atlas SW; Bednarski MD
J Magn Reson Imaging; 2003 Nov; 18(5):530-6. PubMed ID: 14579395
[TBL] [Abstract][Full Text] [Related]
13. Systematic histopathological analysis of different 5-aminolevulinic acid-induced fluorescence levels in newly diagnosed glioblastomas.
Kiesel B; Mischkulnig M; Woehrer A; Martinez-Moreno M; Millesi M; Mallouhi A; Czech T; Preusser M; Hainfellner JA; Wolfsberger S; Knosp E; Widhalm G
J Neurosurg; 2018 Aug; 129(2):341-353. PubMed ID: 29076783
[TBL] [Abstract][Full Text] [Related]
14. Robust texture features for response monitoring of glioblastoma multiforme on T1-weighted and T2-FLAIR MR images: a preliminary investigation in terms of identification and segmentation.
Assefa D; Keller H; Ménard C; Laperriere N; Ferrari RJ; Yeung I
Med Phys; 2010 Apr; 37(4):1722-36. PubMed ID: 20443493
[TBL] [Abstract][Full Text] [Related]
15. Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.
Grabowski MM; Recinos PF; Nowacki AS; Schroeder JL; Angelov L; Barnett GH; Vogelbaum MA
J Neurosurg; 2014 Nov; 121(5):1115-23. PubMed ID: 25192475
[TBL] [Abstract][Full Text] [Related]
16. Pro-angiogenic cellular and genomic expression patterns within glioblastoma influences dynamic susceptibility weighted perfusion MRI.
Barajas RF; Phillips JJ; Vandenberg SR; McDermott MW; Berger MS; Dillon WP; Cha S
Clin Radiol; 2015 Oct; 70(10):1087-95. PubMed ID: 26231469
[TBL] [Abstract][Full Text] [Related]
17. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
[TBL] [Abstract][Full Text] [Related]
18. Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma.
Harris RJ; Cloughesy TF; Pope WB; Godinez S; Natsuaki Y; Nghiemphu PL; Meyer H; Paul D; Behbahanian Y; Lai A; Ellingson BM
J Neurooncol; 2013 Apr; 112(2):257-66. PubMed ID: 23344788
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis.
Server A; Orheim TE; Graff BA; Josefsen R; Kumar T; Nakstad PH
Neuroradiology; 2011 May; 53(5):319-30. PubMed ID: 20625709
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Barajas RF; Chang JS; Segal MR; Parsa AT; McDermott MW; Berger MS; Cha S
Radiology; 2009 Nov; 253(2):486-96. PubMed ID: 19789240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
